The LaNasa-Greco Center for Cancer and Blood Disorders at Children's Hospital offers comprehensive and current therapies for the treatment of all types of malignancies and blood disorders including, but not limited to, leukemia, thalassemia, sickle cell anemia and hemophilia, among many others.
The inpatient unit boasts 18 private rooms in a comfortable, state-of-the-art environment for patients and families. The entire unit is equipped with high efficiency particle air (HEPA) filtration. The highly advanced air handling system allows bone marrow transplants to be performed in any room and is essential to reducing the risk of infection. Located away from other inpatient areas and accessed through a positive pressure vestibule, the unit allows for the highest level of protection for patients.
Though patient care is our primary focus, Children's Hospital is an active participant in clinical and basic research of childhood cancers and blood disorders. Our physicians have access to the most modern therapies for treatment of malignancies and blood disorders in children. The Center for Cancer and Blood Disorders is also a teaching facility for medical students, nursing students and those completing graduate and postgraduate training. The hospital plays a major role in the training of pediatric hematology/oncology fellows. Our program is part of the Louisiana State University Health Sciences Center (LSUHSC) Department of Pediatrics and the Stanley S. Scott Cancer Center.
Our program is affiliated with the Louisiana State University's Minority Community Clinical Oncology Program (MCCOP), which is accredited by the National Cancer Institute. Children's Hospital is also a member of the Children's Oncology Group (COG), a national study group of premier research institutes in the United States and Canada. Our hospital has the only approved COG bone marrow transplant program in Louisiana.
In 2005, despite Hurricane Katrina, more than 846 patients received treatment at Children's Hospital. The center followed 269 oncology patients and 575 hematology patients, including 245 with sickle cell disease.
The Center for Cancer and Blood Disorders at Children's Hospital comprises the largest group of hematology and oncology physicians and nurses in the Gulf South dedicated exclusively to pediatrics. They are specially trained to care for the unique needs of children and work side by side with a medical staff of more than 200 pediatric specialists, including pathologists, radiologists, oncology surgeons and neurosurgeons.
Children's Oncology Group
The Children's Oncology Group (COG) is a National Cancer Institute (NCI) -sponsored cooperative group of individuals and institutions dedicated to treating cancer among children and adolescents. COG's purpose is to:
- improve the diagnosis and management of children and adolescents with cancer, with the aim of curing every newly diagnosed patient;
- investigate the etiology, pathology and pathophysiology of childhood cancer;
- assure that every child with cancer achieves the highest quality of life during and following treatment;
- expeditiously disseminate knowledge of these objectives in all appropriate media.
Children's Hospital and the LSUHSC/Stanley S. Scott Cancer Center have been members of COG for almost 20 years. This allows the Children's Hospital/LSUHSC Minority Community Clinical Oncology Program (MCCOP) to offer innovative and up-to-date clinical trials as part of the NCI-sponsored COG.
- Soft tissue and solid tumors
- Bone Marrow/Hematopoietic
- Stem Cell Transplant Program
- Hemophilia and other blood disorders
- Sickle cell anemia
The members of the Hematology/Oncology section of the Department of Pediatrics have maintained a lively interest in research, in the effort to improve care and expand knowledge regarding the various disease processes that are encountered by patients. One main venue for research has been the Children's Oncology Group
, in which all members of the division participate. Collaborations with other LSUHSC faculty
and Research staff
are continuously being sought out and conducted. In addition, the division maintains a long-time interest in late-effects
and a study of the reasons for their development. Clinical projects involving sickle cell disease, nutrition, alternative medicine, as well as studies entailing chart review, are currently in progress.
Location and Contact Information
200 Henry Clay Avenue New Orleans, LA 70118
Phone: (504) 896-9740
Fax: (504) 896-9758